System for respiratory disorder therapy with selection of stimulation strategies

US2016158091A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016158091-A1
Application numberUS-201514961348-A
CountryUS
Kind codeA1
Filing dateDec 7, 2015
Priority dateDec 8, 2014
Publication dateJun 9, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure relates to a system including a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals. The processor is further configured to determine the effectiveness of a stimulation by detecting a disappearance of the respiratory disorder. The processor is further configured to determine a therapy by selecting a stimulation strategy among several stimulation strategies according to a type of expected or detected disorder.

First claim

Opening claim text (preview).

What is claimed is: 1 . A system for treating a breathing disorder in a patient by stimulation, including: a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder; and at least one effector adapted to receive the stimulations control signals and to deliver a stimulation energy determined by the control signals, wherein the processor is further configured to provide automatic therapy determination comprising dynamically selecting, according to a type of expected or detected respiratory disorder, a stimulation strategy from a set of stored simulation strategies. 2 . The system of claim 1 , wherein the stimulation strategies comprise at least one stimulation strategy of stimulation pulses of a first type and at least one stimulation strategy of stimulation pulses of a second type; wherein the pulses of the second type have at least one of a pulse duration greater than the pulses of the first type and a time interval between pulses greater than the pulses of the first type. 3 . The system of claim 2 , wherein: the pulses of the first type have a pulse duration of between 2 and 3 seconds and a time interval between pulses between 2 and 3 seconds. 4 . The system of claim 1 , wherein the automatic therapy determination further comprises limiting a value of the stimulation energy to a maximum value. 5 . The system of claim 1 , wherein automatic therapy determination further comprises selecting the stimulation energy for a late or early type of therapy depending on the type of disorder expected or detected; the selection comprising either a high energy stimulation strategy and the early therapy or a lower energy stimulation strategy and the later therapy. 6 . The system of claim 1 , wherein the automatic therapy determination further comprises an incremental rising of an energy level from an initial value when the respiratory disorder is still detected. 7 . The system of claim 6 , wherein the automatic therapy determination further comprises a comparison for each energy value incremented to a maximum value. 8 . The system of claim 7 , wherein the automatic therapy determination further comprises forcing the energy level to a value greater than the maximum value when an episode of severe respiratory disorder is detected. 9 . The system of claim 1 , wherein the stimulation energy is a kinesthetic stimulation. 10 . The system of claim 9 , wherein effector is a kinesthetic effector adapted to be applied to a patient's external skin site, and comprising a vibrating electromechanical transducer. 11 . A system for treating a breathing disorder in a patient by kinesthetic stimulation, including: a processor configured to generate kinesthetic stimulation control signals in response to detection of a respiratory disorder; and at least one kinesthetic effector adapted to be applied to a patient's external skin site, and comprising a vibrating electromechanical transducer adapted to receive control signals and to deliver a kinesthetic stimulation energy determined by said control signals; wherein the processor is further configured to provide automatic therapy determination comprising dynamically selecting, according to a type of expected or detected respiratory disorder, a stimulation strategy from a set of stored simulation strategies.

Assignees

Inventors

Classifications

  • A61H23/004Primary

    With mechanical drive, e.g. spring mechanism or vibrating unit being hit for starting vibration and then applied to the body of a patient · CPC title

  • computer controlled · CPC title

  • Sensors or detectors · CPC title

  • partial O2-value · CPC title

  • using specific interfaces or standards, e.g. USB, serial, parallel · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016158091A1 cover?
The disclosure relates to a system including a processor configured to generate stimulation control signals in response to a detection of a respiratory disorder. The system further includes at least one kinesthetic effector with a vibrating electromechanical transducer applied to a site on a patient's skin for delivering a kinesthetic stimulation energy determined by the control signals. The pr…
Who is the assignee on this patent?
Sorin Crm Sas, Inserm Inst De La Rech Médicale, Université Joseph Fourier, and 1 more
What technology area does this patent fall under?
Primary CPC classification A61H23/004. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jun 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).